Home » Intellectual Property

Letters, Testimony & Comments

International Patent Issues Highlighted at House Judiciary Committee Hearing: BIO Submits Biotech's Challenges
  The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
April 26 2012
AIA Oath or Declaration: BIO Comments
Selected Excerpts: The vast majority of BIO’s members are small and medium sized enterprises that currently do not have products...
March 7 2012
2012 Special 301 Report: Biotech's International IP Issues
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
February 14 2012
Strategy for American Innovation: BIO Comments to the U.S. Department of Commerce
April 1, 2011
Re: Request for Comments on the Strategy for American Innovation Subject: Innovation Strategy RFI Email: competitiveness@doc.gov Dear...
April 1 2011
Patent Law Harmonization
June 22, 2007
I'm writing on  behalf of the Biotechnology Industry Organization (BIO) in response to your invitation for public comments on...
June 22 2007
USPTO's proposed 5-year Strategic Plan
October 6, 2006
Perhaps no other industry is as dependent upon patents as is the biotech industry.  In 2004 alone, more than 10% of the PTO's...
October 6 2006
BIO Letter to the House Leadership supporting passage of H.R. 1561, the United States Patent and Trademark Fee Modernization Act of 2003
October 24, 2003
Dear House Leadership: On behalf of the Biotechnology Industry Organization (BIO), I urge you to seek prompt passage of H.R. 1561, the...
October 24 2003
Patent Law Harmonization: Letter to James Rogan
May 6, 2002
Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization
May 6 2002
PTO response to Carl Feldbaum on International Patent Harmonization Efforts
May 6, 2002
May 6 2002
Letter to James Rogan, Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization
May 6, 2002
May 6 2002
Letter to Mr. Nicholas Godici
May 4, 2001
Acting Undersecretary of Commerce and Acting Director of the United States Patent and Trademark Office Regarding Patent Law Harmonization
May 4 2001

Letters, Testimony & Comments

International Patent Issues Highlighted at House Judiciary Committee Hearing: BIO Submits Biotech's Challenges
April 26 2012
  The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
AIA Oath or Declaration: BIO Comments
March 7 2012
Selected Excerpts: The vast majority of BIO’s members are small and medium sized enterprises that currently do not have products...
2012 Special 301 Report: Biotech's International IP Issues
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
Strategy for American Innovation: BIO Comments to the U.S. Department of Commerce
April 1 2011
Re: Request for Comments on the Strategy for American Innovation Subject: Innovation Strategy RFI Email: competitiveness@doc.gov Dear...
Patent Law Harmonization
June 22 2007
I'm writing on  behalf of the Biotechnology Industry Organization (BIO) in response to your invitation for public comments on...
More Letters, Testimony & Comments →

Press Releases

BIO Hosts U.S./China Biotechnology Examiner Workshop with U.S. Patent and Trademark Office and China’s State Intellectual Property Office
April 5 2011
WASHINGTON, D.C. (Tuesday, April 05, 2011) - The Biotechnology Industry Organization (BIO) hosted a U.S./China...
Director of U.S. Patent and Trademark Office to Speak at 2010 BIO International Convention
March 15 2010
WASHINGTON, D.C. (Monday, March 15, 2010) - David Kappos, Director of the U.S. Patent and Trademark Office and Under...